Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner of BlackRock Capital Allocation Term Trust, has sold shares of common stock over two days, reducing its holdings.

Summary

• Saba Capital Management, L.P., a 10% owner of BlackRock Capital Allocation Term Trust (BCAT), has reported the sale of BCAT common stock.
• On May 1, 2025, Saba Capital sold 65,611 shares at a price of $14.78 per share.
• Following this transaction, Saba Capital's indirect beneficial ownership amounted to 11,415,528 shares.
• On May 2, 2025, Saba Capital sold an additional 33,620 shares at $14.82 per share.
• After the second transaction, Saba Capital's indirect beneficial ownership was 11,381,908 shares.
• The transactions were reported by Saba Capital Management, L.P. and Boaz Weinstein, with signatures from Zachary Gindes and Boaz Weinstein.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative as a major shareholder is reducing their position, which could indicate a lack of confidence or a strategic shift.

Negatives

• Saba Capital Management reduced its stake in BlackRock Capital Allocation Term Trust.

Risks

• Continued selling pressure from Saba Capital could negatively impact the stock price of BlackRock Capital Allocation Term Trust.

Industry Context

Hedge funds like Saba Capital frequently adjust their positions in closed-end funds to manage portfolio risk and capitalize on market opportunities.

Stakeholder Impact

• Shareholders may react to the news of Saba Capital reducing its stake.
• The market price of BCAT could be affected by these transactions.

Key Dates

Keywords

Saba Capital Management, BlackRock Capital Allocation Term Trust, BCAT, share sale, beneficial ownership, Form 4, Boaz Weinstein